Table 1 Baseline characteristics by treatment group
FUS(n = 101) | LEEP(n = 124) | U/X2 | P | ||
|---|---|---|---|---|---|
Age | Median (lower quartile, upper quartile) | 26.91(24.00,31.00) | 34.25(32.00,37.00) | U = 9.610 | 0.000 |
range | 18–38 | 21–40 | |||
Educational background | <University | 31(30.69%) | 47(37.90%) | 1.623 | 0.203 |
≥University | 70(69.31%) | 77(62.10%) | |||
Contraception | Condom | 76(75.25%) | 72(58.06%) | 11.999 | 0.002 |
Others* | 10(9.90%) | 32(25.81%) | |||
None | 15(14.85%) | 20(16.13%) | |||
Lifetime sexual partners | 1–2 | 69(68.32%) | 106(85.48%) | 13.483 | 0.000 |
≥ 3 | 32(31.68%) | 18(14.52%) | |||
Parity | 0 | 73(72.28%) | 17(13.71%) | 119.226 | 0.000 |
1 | 26(25.74%) | 74(59.68%) | |||
≥ 2 | 2(1.98%) | 33(26.62%) | |||
HPV status | HPV16/18 infection | 50(49.51%) | 53(42.74%) | 3.435 | 0.179 |
Non-HPV16/18 infection | 47(46.53%) | 69(55.65%) | |||
Negative | 0(0.00%) | 0(0.00%) | |||
Unknown | 4(3.96%) | 2(1.61%) |